Flemming Ørnskov is the CEO of Galderma. Ørnskov is based in Switzerland. Ørnskov was born in 1958 in Esbjerg and educated at Harvard T.H. Chan School of Public Health and INSEAD.
Recent developments
AI summary of recent coverageRecent coverage has focused on Galderma's expansion strategy under Flemming Ørnskov's leadership, including a significant U.S. manufacturing investment and strengthened domestic operations, alongside strong financial performance marked by record sales and raised guidance. The company has also garnered attention for capitalizing on dermatology trends linked to GLP-1 drugs, with commentary on growing demand for aesthetic treatments such as Botox amid new consumer concerns. Coverage reflects Galderma's positioning as a major player navigating rapid growth in the aesthetic and dermatology sector, with L'Oréal acquiring a stake to bolster innovation efforts.
Summarized from the headlines below; see each source for the full story.
Key Facts
Source: Wikidata ↗- Born
- January 24, 1958 · Esbjerg
- Citizenship
- Kingdom of Denmark
- Education
- Harvard T.H. Chan School of Public Health, INSEAD, University of Copenhagen
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Flemming Ørnskov, it will appear here — and tie into the news timeline.
Flemming Ørnskov: FAQ
- What company does Flemming Ørnskov lead?
- Flemming Ørnskov is CEO of Galderma.
- Where was Flemming Ørnskov educated?
- Flemming Ørnskov studied at Harvard T.H. Chan School of Public Health, INSEAD, University of Copenhagen.